• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

输血依赖型地中海贫血患者骨折患病率的多中心研究。

Multicentre study on prevalence of fractures in transfusion-dependent thalassaemic patients.

作者信息

Ruggiero L, De Sanctis V

机构信息

Department of Pediatrics, Card. G. Panico Hospital, Tricase, Lecce, Italy.

出版信息

J Pediatr Endocrinol Metab. 1998;11 Suppl 3:773-8.

PMID:10091145
Abstract

The objective of this study was to determine the prevalence of fractures in transfusion-dependent thalassaemic patients in Italy. Examination of the patients' records revealed that 193 of the 977 observed patients had sustained fractures, with prevalence of 19.7%. Many patients showed multiple and recurrent fractures. Children and adolescents sustained fractures more frequently than adults. The majority of observed patients sustained fractures because of moderate or mild trauma. Our results seem to indicate that Hb pretransfusional levels over 9 or 10 gr% and serum ferritin levels under 1,000 ng/ml cannot always prevent the risk of fracture.

摘要

本研究的目的是确定意大利依赖输血的地中海贫血患者骨折的患病率。对患者记录的检查显示,在977名观察对象中,有193人发生过骨折,患病率为19.7%。许多患者表现出多处和复发性骨折。儿童和青少年比成年人更容易发生骨折。大多数观察对象因中度或轻度创伤而发生骨折。我们的结果似乎表明,输血前血红蛋白水平超过9或10克/百分比以及血清铁蛋白水平低于1000纳克/毫升并不能总是预防骨折风险。

相似文献

1
Multicentre study on prevalence of fractures in transfusion-dependent thalassaemic patients.输血依赖型地中海贫血患者骨折患病率的多中心研究。
J Pediatr Endocrinol Metab. 1998;11 Suppl 3:773-8.
2
High transfusion in children with beta-thalassemia/Hb E: clinical and laboratory assessment of 18 cases.β地中海贫血/Hb E患儿的大量输血:18例临床及实验室评估
Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:96-9.
3
Fractures in transfusion dependent beta thalassemia--an Indian study.输血依赖型β地中海贫血中的骨折——一项印度研究。
Singapore Med J. 2001 May;42(5):196-9.
4
The pattern of bone disease in transfusion-dependent thalassemia major patients.
Isr J Med Sci. 1994 Aug;30(8):577-80.
5
Growth velocity in transfusion dependent prepubertal thalassemia patients: results from a thalassemia center in Malaysia.输血依赖型青春期前地中海贫血患者的生长速度:马来西亚一家地中海贫血中心的研究结果。
Southeast Asian J Trop Med Public Health. 2008 Sep;39(5):900-5.
6
Survival and complications in thalassemia.地中海贫血的生存情况与并发症
Ann N Y Acad Sci. 2005;1054:40-7. doi: 10.1196/annals.1345.006.
7
Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major.重型β地中海贫血患儿的过氧化应激与抗氧化酶
Pediatr Blood Cancer. 2006 Jun;46(7):780-5. doi: 10.1002/pbc.20669.
8
Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.血清铁蛋白水平作为重型地中海贫血患者生长发育受损和青春期延迟的预测指标。
Eur J Haematol. 2005 Feb;74(2):93-100. doi: 10.1111/j.1600-0609.2004.00371.x.
9
Pelvic fractures in pediatric and adult trauma patients: are they different injuries?小儿及成人创伤患者的骨盆骨折:它们是不同的损伤吗?
J Trauma. 2003 Jun;54(6):1146-51; discussion 1151. doi: 10.1097/01.TA.0000044352.00377.8F.
10
Clinical outcome of frequent exposure to Torque Teno virus (TTV) through blood transfusion in thalassemia patients with or without hepatitis C virus (HCV) infection.地中海贫血患者中,无论有无丙型肝炎病毒(HCV)感染,通过输血频繁接触细小病毒B19(TTV)的临床结局。
J Med Virol. 2008 Feb;80(2):365-71. doi: 10.1002/jmv.21070.

引用本文的文献

1
Treatment for osteoporosis in people with beta-thalassaemia.β-地中海贫血患者骨质疏松的治疗。
Cochrane Database Syst Rev. 2023 May 9;5(5):CD010429. doi: 10.1002/14651858.CD010429.pub3.
2
Fracture prevalence in thalassemia: a systematic review and meta-analysis.地中海贫血症的骨折患病率:系统评价和荟萃分析。
Arch Osteoporos. 2021 Nov 13;16(1):171. doi: 10.1007/s11657-021-01026-0.
3
Hematological Diseases and Osteoporosis.血液系统疾病与骨质疏松症
Int J Mol Sci. 2020 May 16;21(10):3538. doi: 10.3390/ijms21103538.
4
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major.地中海贫血症中双能 X 射线吸收法的陷阱。
Endocrine. 2019 Sep;65(3):469-482. doi: 10.1007/s12020-019-02003-x. Epub 2019 Jul 12.
5
Influence of Iron on Bone Homeostasis.铁对骨稳态的影响。
Pharmaceuticals (Basel). 2018 Oct 18;11(4):107. doi: 10.3390/ph11040107.
6
Pathogenesis of Thalassemia Major-associated Osteoporosis: A Review with Insights from Clinical Experience.重型地中海贫血相关骨质疏松症的发病机制:基于临床经验的综述
J Clin Res Pediatr Endocrinol. 2019 May 28;11(2):110-117. doi: 10.4274/jcrpe.galenos.2018.2018.0074. Epub 2018 Jul 11.
7
Clinical Impact and Cellular Mechanisms of Iron Overload-Associated Bone Loss.铁过载相关骨质流失的临床影响及细胞机制
Front Pharmacol. 2017 Feb 21;8:77. doi: 10.3389/fphar.2017.00077. eCollection 2017.
8
Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.地中海贫血相关骨质疏松症:治疗的系统评价及疾病简要概述
Osteoporos Int. 2016 Dec;27(12):3409-3425. doi: 10.1007/s00198-016-3719-z. Epub 2016 Aug 8.
9
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis.雷奈酸锶对重型地中海贫血相关骨质疏松症女性骨量和骨转换的影响。
J Bone Miner Metab. 2016 Sep;34(5):540-6. doi: 10.1007/s00774-015-0689-8. Epub 2015 Jul 24.
10
Evaluation of osteopathy in thalassemia by bone mineral densitometry and biochemical indices.骨密度测定和生化指标评估海洋性贫血症的骨病。
Indian J Pediatr. 2010 Sep;77(9):987-91. doi: 10.1007/s12098-010-0158-2. Epub 2010 Aug 25.